X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (43) 43
oncology (38) 38
humans (37) 37
aged (28) 28
chemotherapy (27) 27
male (27) 27
middle aged (27) 27
female (26) 26
cancer (25) 25
adult (22) 22
colorectal cancer (19) 19
gastric cancer (17) 17
fluorouracil (14) 14
medicine & public health (14) 14
stomach cancer (14) 14
care and treatment (13) 13
treatment outcome (13) 13
analysis (12) 12
metastasis (12) 12
oxaliplatin (12) 12
antineoplastic combined chemotherapy protocols - therapeutic use (11) 11
stomach neoplasms - drug therapy (11) 11
surgical oncology (11) 11
bevacizumab (10) 10
stomach neoplasms - pathology (10) 10
antineoplastic combined chemotherapy protocols - adverse effects (9) 9
gastroenterology (9) 9
irinotecan (9) 9
survival (9) 9
cancer patients (8) 8
cancer research (8) 8
cancer therapies (8) 8
disease-free survival (8) 8
leucovorin (8) 8
medical prognosis (8) 8
tumors (8) 8
5-fluorouracil (7) 7
camptothecin - analogs & derivatives (7) 7
cisplatin (7) 7
cisplatin - administration & dosage (7) 7
colorectal neoplasms - drug therapy (7) 7
fluorouracil - administration & dosage (7) 7
gastroenterology & hepatology (7) 7
paclitaxel (7) 7
radiotherapy (7) 7
retrospective studies (7) 7
colorectal carcinoma (6) 6
medical colleges (6) 6
metastases (6) 6
neoplasm metastasis (6) 6
neutropenia (6) 6
pathology (6) 6
patients (6) 6
pharmacology & pharmacy (6) 6
research (6) 6
s-1 (6) 6
studies (6) 6
survival rate (6) 6
therapy (6) 6
trial (6) 6
1st-line therapy (5) 5
abdominal surgery (5) 5
adenocarcinoma (5) 5
carcinoma (5) 5
colorectal neoplasms - pathology (5) 5
endothelial growth-factor (5) 5
expression (5) 5
follow-up studies (5) 5
japan (5) 5
oncology, experimental (5) 5
peritoneal neoplasms - secondary (5) 5
pharmacokinetics (5) 5
plus cisplatin (5) 5
prognosis (5) 5
young adult (5) 5
1st-line treatment (4) 4
adenocarcinoma - drug therapy (4) 4
aged, 80 and over (4) 4
anemia (4) 4
antimitotic agents (4) 4
antineoplastic agents (4) 4
antineoplastic combined chemotherapy protocols - administration & dosage (4) 4
asian continental ancestry group (4) 4
biomarkers (4) 4
camptothecin - administration & dosage (4) 4
cell lung-cancer (4) 4
clinical trials (4) 4
colon-cancer (4) 4
development and progression (4) 4
drug administration schedule (4) 4
drug therapy (4) 4
efficacy (4) 4
folfiri (4) 4
metastatic colorectal-cancer (4) 4
mutation (4) 4
oxonic acid - administration & dosage (4) 4
peritoneal metastasis (4) 4
phase-iii trial (4) 4
tegafur - administration & dosage (4) 4
adipokines - blood (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 09/2018, Volume 36, Issue 26, pp. 2742 - 2743
Journal Article
Oncology, ISSN 0030-2414, 07/2019, Volume 97, Issue 2, pp. 94 - 101
Objectives: This study aimed to evaluate whether a decrease of computed tomography (CT) value for tumors serves as a predictive marker in patients with... 
Clinical Study | PLACEBO | MULTICENTER | CT value | ANGIOGENESIS | BEVACIZUMAB | COLORECTAL LIVER METASTASES | PREOPERATIVE CHEMOTHERAPY | ONCOLOGY | DOUBLE-BLIND | Ramucirumab | Gastric cancer | GASTROINTESTINAL STROMAL TUMORS | CARCINOMA | IMATINIB MESYLATE
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2018, Volume 36, Issue 15_suppl, pp. TPS4131 - TPS4131
Journal Article
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, ISSN 0368-2811, 03/2019, Volume 49, Issue 3, pp. 210 - 227
Cooperative groups plays important roles in investigator-initiated clinical trials necessary to progress of chemotherapy. We reviewed active cooperative groups... 
LYMPH-NODE DISSECTION | ADJUVANT CHEMOTHERAPY | PERIOPERATIVE CHEMOTHERAPY | gastric cancer | HIGH-DOSE METHOTREXATE | RANDOMIZED-TRIAL | chemotherapy | MESSENGER-RNA LEVELS | GASTROESOPHAGEAL JUNCTION CANCER | PHASE-II TRIAL | SOUTHWEST-ONCOLOGY-GROUP | ONCOLOGY | co-operative group | S-1 PLUS CISPLATIN
Journal Article
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 3/2016, Volume 77, Issue 3, pp. 595 - 603
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2018, Volume 36, Issue 4_suppl, pp. TPS881 - TPS881
TPS881 Background: Trifluridine/tipiracil is an oral combination preparation approved for the treatment of patients with metastatic colorectal cancer (mCRC).... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2019, Volume 37, Issue 4_suppl, pp. 80 - 80
80 Background: Oral fluoropyrimidine plus cisplatin is a standard treatment for advanced gastric cancer, but patients (pts) with severe peritoneal metastasis... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2018, Volume 36, Issue 34_suppl, pp. 96 - 96
96 Background: The integration of oncology and palliative care (IOP) is an emerging issue that has been encouraged by several agencies, including the American... 
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 1, pp. 99 - 108
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2018, Volume 36, Issue 4_suppl, pp. 121 - 121
121 Background: The standard 1st-line chemotherapy for AGC pts with SPM has not been established. F alone is generally used for their treatment because of... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2019, Volume 37, Issue 4_suppl, pp. 578 - 578
578 Background: Primary tumor sidedness is known to be an independent prognostic factor and a predictor for the efficacy of anti-EGFR antibody. However,... 
Journal Article
Cancer Research, ISSN 0008-5472, 07/2017, Volume 77, Issue 13 Supplement, pp. 3818 - 3818
Journal Article
BMC CANCER, ISSN 1471-2407, 07/2019, Volume 19, Issue 1, pp. 652 - 11
BackgroundThere is no standard first-line chemotherapy for advanced gastric cancer with severe peritoneal metastasis. Although fluoropyrimidine is often used,... 
PLUS CISPLATIN | PHASE-III | METHOTREXATE | OXALIPLATIN | FLUOROURACIL | PACLITAXEL | 5-FLUOROURACIL | Chemotherapy | Massive ascites | Inadequate oral intake | THERAPY | ONCOLOGY | S-1 | Peritoneal metastasis | Gastric cancer | Treatment outcome | Care and treatment | Usage | Safety and security measures | Analysis | Stomach cancer | Antimetabolites
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.